Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

News Daily News

Testosterone Therapy Raises Risk of VTE Early but Not Beyond 6 Months

Michael O'Riordan

December 01, 2016

News Daily News

Questions Over Risk-Benefit Balance for IVC Filters Still Vex Clinicians

Caitlin E. Cox

November 17, 2016

News Daily News

IVC 过滤器的风险收益平衡问题仍然困扰临床医生

Caitlin E. Cox

November 17, 2016

News Conference News ESC 2016

Simplified VTE Protocol Rules Out Pulmonary Embolism, Reduces Use of CT Imaging: YEARS Study

Michael O'Riordan

September 02, 2016

News Daily News

Vena Cava Filters Appear to Benefit Only a Small Fraction of Patients With Acute VTE

Todd Neale

April 12, 2016

News Daily News

Meta-analysis: Vena Cava Filters Safe, Effective in Reducing Pulmonary Embolism

March 05, 2014

News Daily News

Similar Efficacy, Less Bleeding With Dabigatran vs. Warfarin in VTE Patients

Yael L. Maxwell

January 01, 2014

News Daily News

Eficacia Similar y Menos Hemorragias con Dabigatran que con Warfarina en Pacientes TEV

Yael L. Maxwell

January 01, 2014

Presentation

RE-COVER 2: Treatment of Acute VTE with Dabigatran or Warfarin and Pooled Analysis

Presenter: Sam Schulman

December 18, 2013

Presentation VEINS 2013

Current Recommendations for VTE Risk Assessment and In-Hospital Prophylaxis

Presenter: Teresa L. Carman

September 21, 2013

Presentation VEINS 2013

Current Recommendations and New Treatment Options for Acute VTE

Presenter: John R. Bartholomew

September 21, 2013

News Daily News

阿哌沙班在急性静脉血栓栓塞治疗方面不逊色于标准疗法

L.A. McKeown

July 05, 2013

News Daily News

El Apixaban No es Inferior a la Terapia Estándar en el Tratamiento de los Tromboembolismos Venosos Agudos

L.A. McKeown

July 05, 2013

News Daily News

Apixaban Noninferior to Standard Therapy for Acute Venous Thromboembolism

L.A. McKeown

July 05, 2013

Advertisement

Testosterone Therapy Raises Risk of VTE Early but Not Beyond 6 Months

Questions Over Risk-Benefit Balance for IVC Filters Still Vex Clinicians

IVC 过滤器的风险收益平衡问题仍然困扰临床医生

Simplified VTE Protocol Rules Out Pulmonary Embolism, Reduces Use of CT Imaging: YEARS Study

Vena Cava Filters Appear to Benefit Only a Small Fraction of Patients With Acute VTE

Meta-analysis: Vena Cava Filters Safe, Effective in Reducing Pulmonary Embolism

Similar Efficacy, Less Bleeding With Dabigatran vs. Warfarin in VTE Patients

Eficacia Similar y Menos Hemorragias con Dabigatran que con Warfarina en Pacientes TEV

RE-COVER 2: Treatment of Acute VTE with Dabigatran or Warfarin and Pooled Analysis

Current Recommendations for VTE Risk Assessment and In-Hospital Prophylaxis

Current Recommendations and New Treatment Options for Acute VTE

阿哌沙班在急性静脉血栓栓塞治疗方面不逊色于标准疗法

El Apixaban No es Inferior a la Terapia Estándar en el Tratamiento de los Tromboembolismos Venosos Agudos

Apixaban Noninferior to Standard Therapy for Acute Venous Thromboembolism

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content